|Home » About NHLBI » Advisory and Peer Review Groups » NHLBAC|
NATIONAL HEART, LUNG, AND BLOOD ADVISORY COUNCIL
Dr. Barbara Alving, Acting Director of the National, Heart, Lung, and Blood Institute opened the meeting and welcomed the Council members to the 213th meeting of the National Heart, Lung, and Blood Advisory Council (NHLBAC). Dr. Alving announced that February is National Heart Month and that there would be a presentation of the Heart Truth Campaign at the meeting.
The search for the Institute Director closed on Friday February 6, 2004. It is expected that a new Director of NHLBI will be appointed by summer 2004.
The new members attending the meeting were:
Dr. Roberto Bolli, Chief of the Division of Cardiology at the University of Louisville.
Budget-Ms Sandra Gault, Budget Officer
Ms. Sandra Gault, Chief, Financial Management Branch, NHLBI, gave an overview of the President's FY 2005 budget request for the NHLBI, which totals $2,964.0 million, a 3.0 percent increase over last year. Funding for research centers is expected to increase by 7.6% in FY 2005, which reflects the increase in the clinical components of its center grants.Update on the Heart Truth Campaign - Ms Terry Long
The Heart Truth is a national awareness campaign for women about heart disease. Ms. Terry Long, Senior Manager for Health Communications and Information Science, Office of Prevention, Education, and Control, NHLBI, described the momentum that has been generated by The Heart Truth campaign since it began in September 2002. Directed primarily at women 40-60 years of age, the campaign seeks to increase awareness that heart disease is the number one cause of death for women and to educate women about its risk factors. The Heart Truth is being conducted in partnership with the American Heart Association, the Office of Women’s Health of the U.S. Department of Health and Human Services, Women Heart—the National Coalition for Women with Heart Disease, and other organizations committed to the health and well-being of women. The centerpiece of the campaign is the “red dress” which is the national symbol for women and heart disease awareness. Over the past year, the red dress and the campaign it symbolizes have received much attention in the media (including Time, Glamour, Newsweek, and major national newspapers), engaged the participation of First Lady Laura Bush, and captured the attention of the fashion industry. Numerous educational materials are available from the campaign website at http://www.hearttruth.gov.February 2004 has been a busy month with:
Ms. Long closed her presentation with a video clip of the fashion show of red dresses featured at Olympus Fashion Week a few days before.
Dr. Baumgartner also noted: the advances in congenital heart surgery the changing pattern of cardiac surgical diseases the emerging role of robotic techniques in cardiothoracic surgery the areas for future clinical investigation Council discussed the need for comprehensive cardiovascular centers within academic institutions to co-locate catheter labs with radiology and surgical departments. Council noted other issues including cardio protection and stenosis of grafts. Dr. Alice Mascette, Director, Clinical and Molecular Medicine Program, Division of Heart and Vascular Diseases, NHLBI, described current and planned NHLBI activities in cardiothoracic surgery and summarized the Institute's main accomplishments. In general surgical research has shown a mortality benefit from surgical revascularization in defined populations, refined and advanced revascularization procedures, developed devices for the failing heart, established heart transplantation as “usual care” and extended advancements to the pediatric population. The Institute is pursuing new directions in cardiovascular cell-based therapies, innovative tissue engineering, and Vascular Endothelial Growth Factor (VEGF) Gene Therapy. There will be a Workshop on Future Directions in Cardiac Surgery in May 2004.
Council discussed the difficulty of initiating and conducting a trial before new and innovative procedures become popularized and widely used.
The report focused on five areas:
The Working Group made the following recommendations to guide the NHLBI in planning its research agenda:
Dr. John Fakunding, Director, Heart Research Program, Division of Heart and Vascular Diseases, NHLBI, summarized NHLBI-supported research in heart failure and indicated that NHLBI will address the recommendations of the Working Group.
Dr. James Kiley, Director, Division of Lung Diseases, NHLBI, explained that the Division of Lung Diseases currently supports three SCOR programs that are in their second (and final) 5-year period of funding. Therefore, in October 2003, a panel of experts met to review ideas solicited from the scientific community for new SCCOR programs. Dr. Kiley presented three new initiatives based on the recommendations of the panel: a SCCOR on Chronic Obstructive Pulmonary Disease (COPD), a SCCOR in Pulmonary Vascular Disease, and a SCCOR in Host Factors in Chronic Lung Diseases. These are proposed to begin in FY 2007 to replace the current SCORs. Council members were enthusiastic about all three initiatives.
Dr. Musson described the Special Action List which has replaced the Special Action Memo and which is significantly reduced in size (3 pages as opposed to >100). Council’s review of this list during the CLOSED portion of the meeting is expected to be more highly focused. Council members were enthusiastic about the changes which will enhance efficiency.
CLOSED PORTIONThis portion of the meeting was closed to the public in accordance with the determination that it was concerned with matters exempt from mandatory disclosure under Sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. appendix 2).
There was a discussion of procedures and policies regarding voting and confidentiality of application materials, committee discussions and recommendations. Members absented themselves from the meeting during discussion of and voting on applications from their own institutions, or other applications in which there was a potential conflict of interest, real or apparent. Members were asked to sign a statement to this effect.
ADJOURNMENTThe meeting was adjourned at 2:45 p.m. on February 12,2004.
I hereby certify that the foregoing minutes are accurate and complete.
Barbara Alving, M.D.
National Heart, Lung, and Blood Advisory Council
Deborah Beebe, Ph.D.
National Heart, Lung, and Blood Advisory Council
NOTE: A complete set of open portion handouts are available from the Executive Secretary.